Wu Z
Helen and Robert Appel Alzheimer's Disease Research Institute, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.
ArticlePsilocybin
A suite of engineered mice for interrogating psychedelic drug actions.
ArticleKetamine
The functional role of ERK activity in esketamine's antidepressant effects.
PreprintKetamine
Esketamine's Therapeutic Effect on Anhedonia: A Post-hoc of a Randomized Controlled Trial
ArticleKetamine
Multiple peripheral inflammatory markers in adolescents with major depressive disorder treated with repeated esketamine infusions: results from a randomized controlled trial.
ArticleKetamine
Transcriptional Signatures of Mitochondrial Metabolism Predict Esketamine-Induced rACC Structural Changes in Adolescent Major Depression.
ArticleKetamine
Immunoreactivity and distribution of Fos in the mouse brain following diverse general anesthetics.
ArticleKetamine
Esketamine Optimized the Efficacy of Dexmedetomidine in Treating Sleep Disorders with Comorbid Depression.
ArticleKetamine
Effect of Different Doses of Esketamine on Postoperative Recovery in Patients Undergoing Gynecologic Laparoscopic Surgery, a Randomized, Double-Blind, Single-Center Clinical Study.
ArticleKetamine
Identification of Key Genes in Esketamine's Therapeutic Effects on Perioperative Neurocognitive Disorders via Transcriptome Sequencing.
ArticleKetamine
Esketamine ameliorates prenatal stress-induced postpartum depression and sex-related behavioral differences in adolescent progeny.
ArticleKetamine
Esketamine improves cognitive function in sepsis-associated encephalopathy by inhibiting microglia-mediated neuroinflammation.
ArticlePsychedelics
A bibliometric analysis of research on psychedelics for depression treatment.
ArticleKetamine
Optimizing esketamine administration for postoperative depression: a comprehensive study on laparoscopic bariatric surgery patients.
PreprintPsilocybin